# To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults

> **NCT02369146** · PHASE2 · COMPLETED · sponsor: **United BioPharma** · enrollment: 29 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** UB-421

## Key facts

- **NCT ID:** NCT02369146
- **Lead sponsor:** United BioPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2017-10-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02369146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02369146, "To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02369146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*